Mohammad A Zubair, MD - Medicare Sleep Medicine in Woodbridge, NJ

Mohammad A Zubair, MD is a medicare enrolled "Internal Medicine - Pulmonary Disease" physician in Woodbridge, New Jersey. He graduated from medical school in 1979 and has 45 years of diverse experience with area of expertise as Sleep Medicine. He is a member of the group practice Mohammad A Zubair Md Llc, Nbimc Department Of Heart, New Jersey Medical And Health Associates Llc and his current practice location is 900 Woodbridge Ctr Dr, Woodbridge, New Jersey. You can reach out to his office (for appointments etc.) via phone at (732) 636-4111.

Mohammad A Zubair is licensed to practice in New Jersey (license number MA58143) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1003872268.

Contact Information

Mohammad A Zubair, MD
900 Woodbridge Ctr Dr,
Woodbridge, NJ 07095-1324
(732) 636-4111
(732) 636-7060



Physician's Profile

Full NameMohammad A Zubair
GenderMale
SpecialitySleep Medicine
Experience45 Years
Location900 Woodbridge Ctr Dr, Woodbridge, New Jersey
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Mohammad A Zubair graduated from medical school in 1979
  NPI Data:
  • NPI Number: 1003872268
  • Provider Enumeration Date: 04/25/2006
  • Last Update Date: 05/06/2011
  Medicare PECOS Information:
  • PECOS PAC ID: 0143265967
  • Enrollment ID: I20050622001065

Medical Identifiers

Medical identifiers for Mohammad A Zubair such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1003872268NPI-NPPES
6523307MedicaidNJ

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RP1001XInternal Medicine - Pulmonary Disease MA58143 (New Jersey)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Bayonne Medical CenterBayonne, NJHospital
Jfk Medical CenterEdison, NJHospital
Newark Beth Israel Medical CenterNewark, NJHospital
Carepoint Health-christ HospitalJersey city, NJHospital

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Mohammad A Zubair allows following entities to bill medicare on his behalf.
Entity NameNbimc Department Of Heart
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1497712632
PECOS PAC ID: 9032176516
Enrollment ID: O20041216000172

News Archive

RTOG phase II clinical trial of Bevacizumab (Avastin) shows positive results for treatment of cervical cancer

An article published in the January issue of the International Journal of Radiation Oncology, Biology and Physics reports results of the Radiation Therapy Oncology Group (RTOG) phase II clinical trial of Bevacizumab (Avastin) in addition to cisplatin and pelvic radiation for locally advanced cervical cancer.

Geisel professor concerned about steroid abuse by adolescents

Leslie Henderson is concerned about steroid abuse, not necessarily by sports luminaries like Barry Bonds and Mark McGwire, but rather by adolescents.

JDRF announces key step on road to artificial pancreas

JDRF announced today another important step on the road to the development of an artificial pancreas - an automated system to better manage the blood sugar of people with type 1 diabetes - with the establishment of a research program to speed the development of faster-acting insulin.

Decades-old FDA approved hypertension drug may delay onset and reduce severity of MS

People suffering from multiple sclerosis may benefit if patent-pending research conducted at Purdue University shows that a decades-old drug approved by the FDA to treat hypertension also delays the onset and reduces the severity of MS symptoms.

Liver transplants worth risk for people who have genetic liver conditions, study finds

Patients faced with the diagnosis of a life-threatening liver disease have to consider the seriousness of having a liver transplant, which can be a definitive cure for many acquired and genetic liver diseases.

Read more Medical News

› Verified 6 days ago

Entity NameWoodbridge Sleep Center Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1942379268
PECOS PAC ID: 8527013044
Enrollment ID: O20050317000714

News Archive

RTOG phase II clinical trial of Bevacizumab (Avastin) shows positive results for treatment of cervical cancer

An article published in the January issue of the International Journal of Radiation Oncology, Biology and Physics reports results of the Radiation Therapy Oncology Group (RTOG) phase II clinical trial of Bevacizumab (Avastin) in addition to cisplatin and pelvic radiation for locally advanced cervical cancer.

Geisel professor concerned about steroid abuse by adolescents

Leslie Henderson is concerned about steroid abuse, not necessarily by sports luminaries like Barry Bonds and Mark McGwire, but rather by adolescents.

JDRF announces key step on road to artificial pancreas

JDRF announced today another important step on the road to the development of an artificial pancreas - an automated system to better manage the blood sugar of people with type 1 diabetes - with the establishment of a research program to speed the development of faster-acting insulin.

Decades-old FDA approved hypertension drug may delay onset and reduce severity of MS

People suffering from multiple sclerosis may benefit if patent-pending research conducted at Purdue University shows that a decades-old drug approved by the FDA to treat hypertension also delays the onset and reduces the severity of MS symptoms.

Liver transplants worth risk for people who have genetic liver conditions, study finds

Patients faced with the diagnosis of a life-threatening liver disease have to consider the seriousness of having a liver transplant, which can be a definitive cure for many acquired and genetic liver diseases.

Read more Medical News

› Verified 6 days ago

Entity NameMohammad A Zubair Md Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1386870541
PECOS PAC ID: 3173678786
Enrollment ID: O20090903000464

News Archive

RTOG phase II clinical trial of Bevacizumab (Avastin) shows positive results for treatment of cervical cancer

An article published in the January issue of the International Journal of Radiation Oncology, Biology and Physics reports results of the Radiation Therapy Oncology Group (RTOG) phase II clinical trial of Bevacizumab (Avastin) in addition to cisplatin and pelvic radiation for locally advanced cervical cancer.

Geisel professor concerned about steroid abuse by adolescents

Leslie Henderson is concerned about steroid abuse, not necessarily by sports luminaries like Barry Bonds and Mark McGwire, but rather by adolescents.

JDRF announces key step on road to artificial pancreas

JDRF announced today another important step on the road to the development of an artificial pancreas - an automated system to better manage the blood sugar of people with type 1 diabetes - with the establishment of a research program to speed the development of faster-acting insulin.

Decades-old FDA approved hypertension drug may delay onset and reduce severity of MS

People suffering from multiple sclerosis may benefit if patent-pending research conducted at Purdue University shows that a decades-old drug approved by the FDA to treat hypertension also delays the onset and reduces the severity of MS symptoms.

Liver transplants worth risk for people who have genetic liver conditions, study finds

Patients faced with the diagnosis of a life-threatening liver disease have to consider the seriousness of having a liver transplant, which can be a definitive cure for many acquired and genetic liver diseases.

Read more Medical News

› Verified 6 days ago

Entity NameGarden State Healthcare Associates Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1700014545
PECOS PAC ID: 8426190687
Enrollment ID: O20100126000693

News Archive

RTOG phase II clinical trial of Bevacizumab (Avastin) shows positive results for treatment of cervical cancer

An article published in the January issue of the International Journal of Radiation Oncology, Biology and Physics reports results of the Radiation Therapy Oncology Group (RTOG) phase II clinical trial of Bevacizumab (Avastin) in addition to cisplatin and pelvic radiation for locally advanced cervical cancer.

Geisel professor concerned about steroid abuse by adolescents

Leslie Henderson is concerned about steroid abuse, not necessarily by sports luminaries like Barry Bonds and Mark McGwire, but rather by adolescents.

JDRF announces key step on road to artificial pancreas

JDRF announced today another important step on the road to the development of an artificial pancreas - an automated system to better manage the blood sugar of people with type 1 diabetes - with the establishment of a research program to speed the development of faster-acting insulin.

Decades-old FDA approved hypertension drug may delay onset and reduce severity of MS

People suffering from multiple sclerosis may benefit if patent-pending research conducted at Purdue University shows that a decades-old drug approved by the FDA to treat hypertension also delays the onset and reduces the severity of MS symptoms.

Liver transplants worth risk for people who have genetic liver conditions, study finds

Patients faced with the diagnosis of a life-threatening liver disease have to consider the seriousness of having a liver transplant, which can be a definitive cure for many acquired and genetic liver diseases.

Read more Medical News

› Verified 6 days ago

Entity NameNew Jersey Medical And Health Associates Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1558673582
PECOS PAC ID: 9133300791
Enrollment ID: O20110302000334

News Archive

RTOG phase II clinical trial of Bevacizumab (Avastin) shows positive results for treatment of cervical cancer

An article published in the January issue of the International Journal of Radiation Oncology, Biology and Physics reports results of the Radiation Therapy Oncology Group (RTOG) phase II clinical trial of Bevacizumab (Avastin) in addition to cisplatin and pelvic radiation for locally advanced cervical cancer.

Geisel professor concerned about steroid abuse by adolescents

Leslie Henderson is concerned about steroid abuse, not necessarily by sports luminaries like Barry Bonds and Mark McGwire, but rather by adolescents.

JDRF announces key step on road to artificial pancreas

JDRF announced today another important step on the road to the development of an artificial pancreas - an automated system to better manage the blood sugar of people with type 1 diabetes - with the establishment of a research program to speed the development of faster-acting insulin.

Decades-old FDA approved hypertension drug may delay onset and reduce severity of MS

People suffering from multiple sclerosis may benefit if patent-pending research conducted at Purdue University shows that a decades-old drug approved by the FDA to treat hypertension also delays the onset and reduces the severity of MS symptoms.

Liver transplants worth risk for people who have genetic liver conditions, study finds

Patients faced with the diagnosis of a life-threatening liver disease have to consider the seriousness of having a liver transplant, which can be a definitive cure for many acquired and genetic liver diseases.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mohammad A Zubair is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Mohammad A Zubair, MD
900 Woodbridge Ctr Dr,
Woodbridge, NJ 07095-1324

Ph: (732) 636-4111
Mohammad A Zubair, MD
900 Woodbridge Ctr Dr,
Woodbridge, NJ 07095-1324

Ph: (732) 636-4111

News Archive

RTOG phase II clinical trial of Bevacizumab (Avastin) shows positive results for treatment of cervical cancer

An article published in the January issue of the International Journal of Radiation Oncology, Biology and Physics reports results of the Radiation Therapy Oncology Group (RTOG) phase II clinical trial of Bevacizumab (Avastin) in addition to cisplatin and pelvic radiation for locally advanced cervical cancer.

Geisel professor concerned about steroid abuse by adolescents

Leslie Henderson is concerned about steroid abuse, not necessarily by sports luminaries like Barry Bonds and Mark McGwire, but rather by adolescents.

JDRF announces key step on road to artificial pancreas

JDRF announced today another important step on the road to the development of an artificial pancreas - an automated system to better manage the blood sugar of people with type 1 diabetes - with the establishment of a research program to speed the development of faster-acting insulin.

Decades-old FDA approved hypertension drug may delay onset and reduce severity of MS

People suffering from multiple sclerosis may benefit if patent-pending research conducted at Purdue University shows that a decades-old drug approved by the FDA to treat hypertension also delays the onset and reduces the severity of MS symptoms.

Liver transplants worth risk for people who have genetic liver conditions, study finds

Patients faced with the diagnosis of a life-threatening liver disease have to consider the seriousness of having a liver transplant, which can be a definitive cure for many acquired and genetic liver diseases.

Read more News

› Verified 6 days ago


Internal Medicine Doctors in Woodbridge, NJ

Dr. Nancy Carol Somer, MD
Pulmonary Disease
Medicare: Medicare Enrolled
Practice Location: 453 Amboy Ave, Woodbridge, NJ 07095
Phone: 732-636-6612    
Luca Desimone, M.D.
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 1000 Route 9 N, Suite 302, Woodbridge, NJ 07095
Phone: 732-634-0036    Fax: 732-855-9395
Louis Friedman, M.D.
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 1000 Route 9 N, Suite 302, Woodbridge, NJ 07095
Phone: 732-634-0036    Fax: 732-855-9395
Dr. Richard A Goldstein, M.D.
Pulmonary Disease
Medicare: Medicare Enrolled
Practice Location: 453 Amboy Ave, Woodbridge, NJ 07095
Phone: 732-634-1221    
Dr. Xiaowei Zhang, M.D.
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: Woodbridge Developmental Center, Rahway Avenue, Woodbridge, NJ 07095
Phone: 732-499-5951    
Mr. Omar Q Awan, M.D.
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 42 Highview Dr, Woodbridge, NJ 07095
Phone: 732-397-6000    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.